"10.1371_journal.pone.0056899","plos one","2013-02-20T00:00:00Z","Carol Dobson-Stone; Marianne Hallupp; Clement T Loy; Elizabeth M Thompson; Eric Haan; Carolyn M Sue; Peter K Panegyres; Cristina Razquin; Manuel Seijo-Martínez; Ramon Rene; Jordi Gascon; Jaume Campdelacreu; Birgit Schmoll; Alexander E Volk; William S Brooks; Peter R Schofield; Pau Pastor; John B J Kwok","Neuroscience Research Australia, Sydney, Australia; School of Medical Sciences, University of New South Wales, Sydney, Australia; Huntington Disease Service, Westmead Hospital, Sydney, Australia; Sydney School of Public Health, University of Sydney, Sydney, Australia; South Australia Clinical Genetics Service, Women's and Children's Hospital, Adelaide, Australia; Department of Paediatrics, University of Adelaide, Adelaide, Australia; Department of Neurogenetics, Kolling Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia; Neurodegenerative Disorders Research Pty Ltd, Subiaco, Australia; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, University of Navarra, Pamplona, Spain; Department of Neurology, Hospital do Salnés, Pontevedra, Spain; Department of Neurology, Hospital de Bellvitge, Barcelona, Spain; Institute of Human Genetics, University Hospital Ulm, Ulm, Germany; Department of Neurology, Clínica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain; CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain","Conceived and designed the experiments: CDS PRS PP JBJK. Performed the experiments: CDS MH BS AEV. Analyzed the data: CDS WSB JBJK. Contributed reagents/materials/analysis tools: CTL EMT EH CMS PKP CR MSM RR JG JC WSB PP. Wrote the paper: CDS CTL WSB PRS PP JBJK.","Dr. Dobson-Stone and Dr. Kwok receive grant funding from the National Health and Medical Research Council of Australia (NHMRC). Dr. Panegyres provides services for Neurodegenerative Disorders Research Pty Ltd, a not-for-profit organization. Prof. Schofield receives grant funding from the NHMRC, Australian Research Council, National Institute of Health, Wicking Foundation and Beyond Blue Foundation. He has received speaker fees from Janssen-Cilag. He has held stock options (unexercised and now lapsed) in Brain Resource Ltd. He is Executive Director & CEO (paid employment) of Neuroscience Research Australia (a not-for-profit company) and Director (unpaid) of not-for-profit companies Neuroscience Research Australia Foundation, The Health-Science Alliance, and Neuroscience Australia (NSA). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","02","Carol Dobson-Stone","CDS",18,TRUE,4,4,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
